Nrdp1, as an E3 liagse, has been extensively investigated for apoptosis and inflammation activity in cancer cells and other cell types [5], [6], [7], [8], [9], [10], [11]; however, the effect of Nrdp1 on DOX-induced cardiotoxicity and underlying mechanisms has been less well studied. This evidence concerns the gene RNF41 and cancer.